Business Wire

ASM Global’s Savor Team USA Heads to Singapore to Vie for Global Title in World’s Only Young Chef Young Waiter and Mixologist Competition

9.8.2024 16:00:00 EEST | Business Wire | Press release

Share

ASM Global’s culinary division SAVOR, which provides elevated food experiences for the globe’s most prestigious arenas, stadiums, convention/exhibition centers and performing arts venues, has announced the national winners of the American round of the world’s only competition for young culinary and hospitality talent.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240809474691/en/

Mixologist Winner Marco Guillen, Four Seasons, Napa Valley, California. (Photo: Business Wire)

Thomas Mendel, chef from Hamel Winery; Jaclyn Bisantz, waitress from Harbor House; and Marco Guillen, mixologist from Four Seasons Napa, were crowned as winners of the U.S. leg of the renowned World Young Chef Young Waiter Young Mixologist (WorldYYY) competition — the only event of its kind.

“This syncs very nicely with the work ASM Global does nationally to develop deep relationships with our local communities and reach out to educate, train and employ culinary talent via scholarship, internship and apprenticeship programs,” said Shaun Beard, SAVOR’s senior vice present of food and beverage.

“As ASM Global continues to elevate the food experience in many of the world’s premiere venues, these up-and-coming talents will be part of our universe,” Beard said. “The composure, creativity and determination we’ve seen from all the competitors in this high-pressure situation was truly unmatched and is proof that we have so much to look forward to from these young stars. We are proud to help pave the way for them and are excited to see what they do next.”

SAVOR’s Team USA members will next compete in the WorldYYY finals at Swissôtel The Stamford in Singapore this November. They will showcase their abilities to world-class chefs, hospitality experts and esteemed mixologists. A total of 36 contestants from 12 countries will compete for the world titles of Best Young Chef, Young Waiter and Young Mixologist.

The finals ofYYY USA recently took place at the prestigious The Culinary Institute of America at Copia (CIA) in Napa, California, with a panel of expert judges, including Master Chef Roland Passot, propriétaire and chief culinary officer; Tournament of Champions’ Tracey Shepos Cenami, executive chef and cheese specialist at Kendall-Jackson Wine Estate and Gardens; and Food Network Chef Adam Sobel, partner of Mina Group anointing the winners.

ASM Global’s SAVOR division became a strategic partner of the competition nearly five years ago as part of its worldwide commitment to nurturing and identifying new talent, introducing them to the hospitality space and showcasing them to renowned culinary industry leaders.

About SAVOR

SAVOR is the culinary division of ASM Global, the world’s No. 1 development and full-service venue company with a portfolio of more than 400 of the world’s most prestigious arenas, stadiums, convention/exhibition centers and performing arts venues network spanning five continents. The team at SAVOR provides elevated and curated guest experiences at every event, from the food preparation to the beverage offerings, whether for intimate VIP experiences or banquets with over 20,000 guests. In addition to authentic, chef-driven food, the core elements of SAVOR's food vision include partnerships with local growers, producers and community members; a commitment to using antibiotic-free meats and poultry; and dedication to minimizing impact on the environment through robust sustainability, recycling and composting programs. For more information, please visit savorasmglobal.com.

About YYY

Since its establishment in 1979, the Young Chef Young Waiter competition has continued to promote hospitality as a career of choice, a profession and a vocation. Today, with its new revitalized format, Young Chef Young Waiter continues to honor the next culinary and service stars globally. World Young Chef Young Waiter Young Mixologist’s, in partnership with Great Campaign U.K. and Northern Ireland and The Culinary Institute of America, mission is to discover the best young talents in the industry. The competition is open to young chefs, waiters and mixologists age 28 and under from diverse backgrounds. YYY ensures these young talents are equipped with relevant skills, current knowledge and a network to help them succeed in the world of hospitality.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240809474691/en/

Contacts

Jim Yeager
breakwhitelight (for ASM Global)
jim@breakwhitelight.com
Mobile: 818-264-6812

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release

2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye